Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug;35(3):145-152.
doi: 10.1055/s-0041-1731461. Epub 2021 Jul 15.

Current Advances in Hypertrophic Scar and Keloid Management

Natasha Barone  1 , Tyler Safran  2 , Joshua Vorstenbosch  2 , Peter G Davison  2 , Sabrina Cugno  2 , Amanda M Murphy  2   3
Affiliations
Review

Current Advances in Hypertrophic Scar and Keloid Management

Natasha Barone et al. Semin Plast Surg. 2021 Aug.

Abstract

Hypertrophic scars and keloids are caused by excessive tissue response to dermal injury due to local fibroblast proliferation and collagen overproduction. This response occurs because of pathologic wound healing due to dysregulation in the inflammatory, proliferative, and/or remodeling phase. Patients with hypertrophic scars or keloids report reduced quality of life, physical status, and psychological health. Hypertrophic scars or keloids will develop in 30 to 90% of individuals, and despite their prevalence, treatment remains a challenge. Of the treatments currently available for hypertrophic scars and keloids few have been adequately supported by studies with appropriate experimental design. Here, we aim to review the available literature to provide up-to-date information on the etiology, epidemiology, histology, pathophysiology, prevention, and management options available for the treatment of hypertrophic scars and keloids and highlight areas where further research is required.

Keywords: fibrosis; hypertrophic scar; keloid; scarring.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

References

    1. Zhu Z, Ding J, Tredget E E. The molecular basis of hypertrophic scars. Burns Trauma. 2016;4:2–2. - PMC - PubMed
    1. Bock O, Schmid-Ott G, Malewski P, Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res. 2006;297(10):433–438. - PubMed
    1. Lee H J, Jang Y J. Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and keloids. Int J Mol Sci. 2018;19(03):E711–E711. - PMC - PubMed
    1. Monstrey S, Middelkoop E, Vranckx J J. Updated scar management practical guidelines: non-invasive and invasive measures. J Plast Reconstr Aesthet Surg. 2014;67(08):1017–1025. - PubMed
    1. Baisch A, Riedel F.Hyperplastic scars and keloids. Part I: basics and prevention [in German] HNO 20065411893–904., quiz 905 - PubMed